Seroatlas · Human Serome Atlas

BCL3

B-cell lymphoma 3 protein

Also known as: BCL3_HUMAN, BCL4, D19S37

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P20749
Gene
BCL3
Ensembl
ENSG00000069399
Chromosome
19
Canonical length
454 aa
Protein class
Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors
Subcellular location
Nucleoplasm,Vesicles,Midbody,Basal body,Cytosol
Quaternary structure
Homodimer

OverviewNCBI Gene

This gene is a proto-oncogene candidate. It is identified by its translocation into the immunoglobulin alpha-locus in some cases of B-cell leukemia. The protein encoded by this gene contains seven ankyrin repeats, which are most closely related to those found in I kappa B proteins. This protein functions as a transcriptional co-activator that activates through its association with NF-kappa B homodimers. The expression of this gene can be induced by NF-kappa B, which forms a part of the autoregulatory loop that controls the nuclear residence of p50 NF-kappa B. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

454 residues, UniProt reviewed canonical sequence.

>P20749|BCL3
     1  MPRCPAGAMD EGPVDLRTRP KAAGLPGAAL PLRKRPLRAP SPEPAAPRGA AGLVVPLDPL
    61  RGGCDLPAVP GPPHGLARPE ALYYPGALLP LYPTRAMGSP FPLVNLPTPL YPMMCPMEHP
   121  LSADIAMATR ADEDGDTPLH IAVVQGNLPA VHRLVNLFQQ GGRELDIYNN LRQTPLHLAV
   181  ITTLPSVVRL LVTAGASPMA LDRHGQTAAH LACEHRSPTC LRALLDSAAP GTLDLEARNY
   241  DGLTALHVAV NTECQETVQL LLERGADIDA VDIKSGRSPL IHAVENNSLS MVQLLLQHGA
   301  NVNAQMYSGS SALHSASGRG LLPLVRTLVR SGADSSLKNC HNDTPLMVAR SRRVIDILRG
   361  KATRPASTSQ PDPSPDRSAN TSPESSSRLS SNGLLSASPS SSPSQSPPRD PPGFPMAPPN
   421  FFLPSPSPPA FLPFAGVLRG PGRPVPPSPA PGGS

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against BCL3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.47
Highest tissue expression
169 nTPM

Expression across tissuesHPA

Tissue

  • liver: 169 nTPM
  • lung: 95 nTPM
  • esophagus: 75 nTPM
  • adipose tissue: 70 nTPM
  • spleen: 63 nTPM
  • bone marrow: 51 nTPM

Single-cell type

  • neutrophils: 368 nCPM
  • breast hormone-responsive cells: 163 nCPM
  • breast secretory cells: 131 nCPM
  • esophageal apical cells: 118 nCPM
  • monocytes: 110 nCPM
  • urothelial cells: 101 nCPM

Immune cell

  • neutrophil: 20 nTPM
  • eosinophil: 5.5 nTPM
  • plasmacytoid DC: 3.1 nTPM
  • classical monocyte: 2.7 nTPM
  • myeloid DC: 2.6 nTPM
  • NK-cell: 2.3 nTPM

Brain region

  • medulla oblongata: 15 nTPM
  • thalamus: 9.6 nTPM
  • pons: 8.5 nTPM
  • spinal cord: 8.4 nTPM
  • choroid plexus: 8.1 nTPM
  • midbrain: 7.8 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about BCL3.

Disease | ImmuneIEDB

Conditions an epitope on BCL3 was assayed in.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.22
gnomAD pLI
0.99
gnomAD missense Z
2.27
DepMap mean gene effect
0.07
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of BCL3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads BCL3 as an antibody target. Whether an autoantibody or antibody against BCL3 could matter depends on whether native BCL3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

BCL3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label BCL3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/BCL3. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...